| Heart failure in pediatric septic shock: utilizing inotropic support. | |
| | |
MedLine Citation:
|
PMID: 11593066 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Septic shock presents a unique challenge in the pediatric patient. Sepsis stimulates the release of inflammatory mediators that can compromise cardiac function. Oxygen extraction abnormalities, diminished responses to adrenergic agonists, and impaired ventricular function often result. After fluid resuscitation and antibiotic therapy, careful cardiovascular assessment is needed to administer appropriate inotropic and vasoactive drugs. |
| | |
Authors:
|
S Tabbutt |
Related Documents
:
|
19939836 - Sepsis and the heart. 18387436 - Inappropriate implantable cardioverter-defibrillator shocks in madit ii: frequency, mec... 16374966 - Ecg of the month. hypotension, pulmonary edema, and an irregular cardiac rhythm in a 50... 18556106 - Recurrent ventricular fibrillation during advanced life support care of patients with p... 1620266 - Regression and stabilization of coronary artery lesions. angiographic trials move beyon... 3429936 - Transoesophageal echocardiographic monitoring of left ventricular function. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Critical care medicine Volume: 29 ISSN: 0090-3493 ISO Abbreviation: Crit. Care Med. Publication Date: 2001 Oct |
Date Detail:
|
Created Date: 2001-10-10 Completed Date: 2001-11-01 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0355501 Medline TA: Crit Care Med Country: United States |
Other Details:
|
Languages: eng Pagination: S231-6 Citation Subset: AIM; IM |
Affiliation:
|
Cardiology and Critical Care Medicine, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. tabbutt@email.chop.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Agonists
/
therapeutic use Cardiac Output, Low / diagnosis, drug therapy*, etiology Cardiomyopathies / diagnosis, drug therapy*, etiology Cardiotonic Agents / therapeutic use* Child Humans Phosphodiesterase Inhibitors / therapeutic use Shock, Septic / complications*, physiopathology Vasoconstrictor Agents / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Agonists; 0/Cardiotonic Agents; 0/Phosphodiesterase Inhibitors; 0/Vasoconstrictor Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cellular and molecular aspects of myocardial dysfunction.
Next Document: Optimizing treatment for chronic congestive heart failure in children.